DRUG ACETYLATION IN BREAST-CANCER

被引:16
作者
WEBSTER, DJT
FLOOK, D
JENKINS, J
HUTCHINGS, A
ROUTLEDGE, PA
机构
[1] UNIV COLL CARDIFF,DEPT PHARMACOL & THERAPEUT,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES
[2] UNIV WALES COLL MED,LLANDOUGH HOSP,DEPT SURG,PENARTH CF6 1XX,S GLAM,WALES
[3] UNIV WALES COLL MED,LLANDOUGH HOSP,DEPT CLIN PHARMACOL,PENARTH CF6 1XX,S GLAM,WALES
关键词
D O I
10.1038/bjc.1989.260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:236 / 237
页数:2
相关论文
共 9 条
[1]   ACETYLATOR PHENOTYPE IN PATIENTS WITH BREAST-CANCER [J].
BULOVSKAYA, LN ;
KRUPKIN, RG ;
BOCHINA, TA ;
SHIPKOVA, AA ;
PAVLOVA, MV .
ONCOLOGY, 1978, 35 (04) :185-188
[2]  
BULOVSKAYA LN, 1976, ONCOLOGY, V2, P59
[3]   DETERMINATION OF ACETYLATOR STATUS IN UREMIA [J].
FINE, A ;
SUMNER, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (05) :475-476
[4]  
HUGHES LE, 1987, LANCET, V2, P1316, DOI 10.1016/S0140-6736(87)91204-9
[5]   A METHOD TO PREVENT THE LOSS OF ISONIAZID AND ACETYLISONIAZID IN HUMAN-PLASMA [J].
HUTCHINGS, A ;
MONIE, RD ;
SPRAGG, B ;
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (02) :263-266
[6]   A SIMPLE METHOD FOR DETERMINING ACETYLATOR PHENOTYPE USING ISONIAZID [J].
HUTCHINGS, A ;
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (03) :343-345
[7]  
HUTCHINGS A, 1983, J CHROMATOGR, V277, P385, DOI 10.1016/S0378-4347(00)84863-X
[8]   SALIVA AND PLASMA-CONCENTRATIONS OF ISONIAZID AND ACETYLISONIAZID IN MAN [J].
HUTCHINGS, AD ;
MONIE, RD ;
SPRAGG, BP ;
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (05) :585-589
[9]  
MCQUEEN EG, 1980, DRUG TREATMENT